ArticleBMC infectious diseases2025
Association of vitamin D receptor mRNA expression, vitamin D deficiency and genetic variant in patients with multi-drug resistant pulmonary tuberculosis.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of vitamin D receptor genetic variants with therapeutic response in multidrug-resistant pulmonary tuberculosis: a systematic review.Frontiers in cellular and infection microbiology · 2026Pooled it
- Vitamin D receptor polymorphisms as predictors of pediatric infectious disease prevalence and outcome: an overview of available evidence.Frontiers in immunology · 2026Review
- Vitamin D receptorTherapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMulti-drug resistant pulmonary tuberculosis (MDR-TB), is a serious threat to world health. Serum levels of vitamin D, a ligand for the VDR that controls VDR mRNA expression, are still poorly understood in MDR-TB.
objectiveTo study the association of mRNA expression with low vitamin D levels and VDR polymorphisms in patients with MDR-TB compared to normal controls.
methodsStudy groups consisted of sputum smears and culture-positive MDR-TB at two hospitals in New Delhi, and normal controls were enrolled from a North Indian population. A total 100 (50 MDR-TB subjects and 50 controls) were consecutively enrolled. VDR mRNA expression in peripheral blood mononuclear cells (PBMC) was analysed by Real-time PCR. Serum 25-hydroxyvitamin D, intact parathyroid hormone (iPTH), and calcium (ionized and total) levels were measured, and the correlation between variables was determined. The association between VDR genotype and VDR mRNA expression was studied between MDR-TB and normal controls together with the genotypic and allelic frequencies of the FokI, BsmI, and TaqI VDR polymorphisms were also assessed in between the two groups.
resultsTo investigate the role of VDR gene expression and FokI polymorphism in MDR-TB, a total of 100 patients were split into two groups. VDR mRNA expression significantly decreased in MDR-TB patients, being 0.6 times lower than in healthy controls. Notably, the ff genotype was associated with reduced VDR expression, indicating a functional impact on gene regulation. However, there was no appreciable variation in the groups' distribution of FokI alleles and genotypes. These findings highlight the importance of merging genetic and expression data, showing that while the ff variation influences individual expression, it does not distinguish MDR-TB patients from controls.
conclusionIn present study, the VDR gene's FokI polymorphism affects the levels of VDR mRNA expression, with the ff genotype linked to lower expression in both MDR-TB patients and healthy individuals. Nonetheless, there were no appreciable differences in the genotypic and allelic frequencies of FokI between the groups. These findings suggest that the location of the FokI variation in the population may not be as important to MDR-TB susceptibility as its functional impact on gene expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.